IL-9 expression contributes to the cellular composition in Hodgkin lymphoma

European Journal of Haematology

Volumn 76, Issue 4, 2006, Pages 278-283

  Glimelius, Ingrid ^a,b   Edström, Annika ^a   Amini, Rose Marie ^a   Fischer, Marie ^a   Nilsson, Gunnar ^a   Sundström, Christer ^a   Enblad, Gunilla ^a   Molin, Daniel ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hodgkin lymphoma; IL 9; Mast cells and eosinophils; Nodular sclerosis

Indexed keywords

INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DATA ANALYSIS; EOSINOPHIL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HISTOLOGY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MAST CELL; NODULAR SCLEROSIS HODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CYTOPLASM; EOSINOPHILS; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-9; MALE; MAST CELLS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-9;

EID: 33644840611     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00613.x     Document Type: Article

References (32)

1. C rocker J S mith PJ. A quantitative study of mast cells in Hodgkin's disease J Clin Pathol 1984 37 519 522
2. E nblad G S undstrom C G limelius B. Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis Hematol Oncol 1993 11 187 193
3. M olin D E dstrom A G limelius I G limelius B N ilsson G S undstrom C E nblad G. Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma Br J Haematol 2002 119 122 124
4. J affe ES H arris NL S tein H V ardiman JW eds World Health Organization classification of tumours In Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues Lyon IARC Press 2001
5. M olin D. Bystander cells and prognosis in Hodgkin lymphoma. Review based on a doctoral thesis Ups J Med Sci 2004 109 179 228
6. P into A G attei V Z agonel V et al. Hodgkin's disease: a disorder of dysregulated cellular cross-talk Biotherapy 1998 10 309 320
7. S kinnider BF M ak TW. The role of cytokines in classical Hodgkin lymphoma Blood 2002 99 4283 4297
8. R enauld JC K ermouni A V ink A L ouahed J V an S nick J. Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis J Leukoc Biol 1995 57 353 360
9. M arshall NA C hristie LE M unro LR C ulligan DJ J ohnston PW B arker RN V ickers MA. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma Blood 2004 103 1755 1762
10. R enauld JC D ruez C K ermouni A H oussiau F U yttenhove C V an R oost E V an S nick J. Expression cloning of the murine and human interleukin 9 receptor cDNAs Proc Natl Acad Sci USA 1992 89 5690 5694
11. M erz H H oussiau FA O rscheschek K et al. Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma Blood 1991 78 1311 1317
12. G russ HJ B rach MA D rexler HG B ross KJ H errmann F. Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells Cancer Res 1992 52 1026 1031
13. F ischer M B ijman M M olin D C ormont F U yttenhove C van S nick J S undstrom C E nblad G N ilsson G. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma Leukemia 2003 17 2513 2516
14. von W asielewski R S eth S F ranklin J F ischer R H ubner K H ansmann ML D iehl V G eorgii A. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors Blood 2000 95 1207 1213
15. P into A A ldinucci D G loghini A et al. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line Blood 1996 88 3299 3305
16. M olin D F ischer M X iang Z L arsson U H arvima I V enge P N ilsson K S undstrom C E nblad G N ilsson G. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease Br J Haematol 2001 114 616 623
17. L ouahed J Z hou Y M aloy WL et al. Interleukin 9 promotes influx and local maturation of eosinophils Blood 2001 97 1035 1042
18. G ounni AS G regory B N utku E et al. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils Blood 2000 96 2163 2171
19. M atsuzawa S S akashita K K inoshita T I to S Y amashita T K oike K. IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor J Immunol 2003 170 3461 3467
20. B ennett MHMK E asterling MJ V aughan Hudson B J elliffe AM Vaughan Hudson G. The prognostic significance of cellular subtypes in Nodular Sclerosis Hodgkin's disease: an analysis of 271 non-laparotomised cases (BNLI report No. 22) Clin Rad 1983 34 497 501
21. E nblad G G limelius B S undstrom C. Treatment outcome in Hodgkin's disease in patients above the age of 60: a population-based study Ann Oncol 1991 2 297 302
22. A mini RM E nblad G G ustavsson A E kman T E rlanson M H aapaniemi E G limelius B. Treatment outcome in patients younger than 60 years with advanced stages (IIB-IV) of Hodgkin's disease: the Swedish National Health Care Programme experience Eur J Haematol 2000 65 379 389
23. G limelius I M olin D A mini RM G ustavsson A G limelius B E nblad G. Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB Eur J Haematol 2003 71 327 333
24. M olin D E nblad G G ustavsson A E kman T E rlanson M H aapaniemi E G limelius B. Early and intermediate stage Hodgkin's lymphoma - report from the Swedish National Care Programme Eur J Haematol 2003 70 172 180
25. C arbon PPKH M usshoff K S mithers DW T ubiana M. Report on the committee on Hodgkin's disese staging Cancer Res 1971 31 1960 1961
26. L ister TA C rowther D S utcliffe SB G latstein E C anellos GP Y oung RC R osenberg SA C oltman CA T ubiana M. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: cotswolds meeting J Clin Oncol 1989 7 1630 1636
27. P oppema S van den B erg A. Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas Semin Cancer Biol 2000 10 345 350
28. A ldinucci D L orenzon D O livo K R apana B G attei V. Interactions between tissue fibroblasts in lymph nodes and hodgkin/reed-sternberg cells Leuk Lymphoma 2004 45 1731 1739
29. H su SM H su PL. Autocrine and paracrine functions of cytokines in malignant lymphomas Biomed Pharmacother 1994 48 433 444
30. H ernnas J S arnstrand B L indroth P P eterson CG V enge P M almstrom A. Eosinophil cationic protein alters proteoglycan metabolism in human lung fibroblast cultures Eur J Cell Biol 1992 59 352 363
31. M olin D G limelius B S undstrom C V enge P E nblad G. The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease Leuk Lymphoma 2001 42 457 465
32. F ischer M J uremalm M O lsson N B acklin C S undstrom C N ilsson K E nblad G N ilsson G. Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue Int J Cancer 2003 107 197 201